AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion

Jennifer Kay Callaway, Andrew J Lawrence, Bevyn Jarrott

Research output: Contribution to journalArticleResearchpeer-review

26 Citations (Scopus)
Original languageEnglish
Pages (from-to)787 - 800
Number of pages14
JournalNeuropharmacology
Volume44
Issue number6
DOIs
Publication statusPublished - 2003

Cite this